Time To Add-On Medication Use for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy

被引：0

|

作者：

Qiu, Ying

Fu, Alex Z.

Radican, Larry

机构：

来源：

DIABETES | 2010年 / 59卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A70 / +

页数：2

相关论文

共 50 条

[1] TIME TO ADD-ON MEDICATION USE FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) WHO FAILED METFORMIN MONOTHERAPY
Qiu, Y.
Fu, A. Z.
Radican, L.
[J]. VALUE IN HEALTH, 2010, 13 (07) : A299 - A299
[2] GlyCemic Control with Add-On Medication Use for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy
Fu, Alex Z.
Qiu, Ying
Radican, Larry
[J]. DIABETES, 2010, 59 : A612 - A613
[3] Patient Characteristics Associated with Add-On Medication Treatment for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy
Qiu, Ying
Fu, Alex Z.
Radican, Larry
[J]. DIABETES, 2010, 59 : A604 - A604
[4] Efficacy and Safety of Saxagliptin Add-on to Metformin Compared with Acarbose Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin Monotherapy
Du, Jin
Liang, Li
Fang, Hui
Xu, Fengmei
Li, Wei
Shen, Liya
Mu, Yiming
[J]. DIABETES, 2016, 65 : A293 - A293
[5] Time to add-on medication use for patients with type 2 diabetes who failed metformin mono therapy
Qiu, Y.
Fu, A. Z.
Radican, L.
[J]. DIABETOLOGIA, 2010, 53
[6] Empagliflozin (EMPA) for ≥76 Weeks as Add-on to Metformin in Patients with Type 2 Diabetes (T2DM)
Merker, Ludwig
Haering, Hans-Ulrich
Christiansen, Anita Vedel
Roux, Flavien
Salsali, Afshin
Kim, Gabriel
Meinicke, Thomas
Woerle, Hans J.
Broedl, Uli C.
[J]. DIABETES, 2014, 63 : A278 - A278
[7] Empagliflozin (EMPA) for ≥76 Weeks As Add-on to Metformin in Patients with Type 2 Diabetes (T2DM)
Merker, Ludwig
Haering, Hans-Ulrich
Christiansen, Anita Vedel
Roux, Flavien
Salsali, Afshin
Kim, Gabriel
Meinicke, Thomas
Woerle, Hans-Juergen
Broedl, Uli C.
[J]. ENDOCRINE REVIEWS, 2014, 35 (03)
[8] Vildagliptin as add-on to insulin in patients with type 2 diabetes (T2DM)
Fonseca, Vivian
Dejager, Sylvie
Albrecht, Diego
Shirt, Lynda
Schweizer, Anja
[J]. DIABETES, 2006, 55 : A111 - A111
[9] Ramate as add-on to metformin (MET) in obese subjects with type 2 diabetes (T2DM)
Toplak, H
Vercruysse, F
Sun, X
Fitchet, M
[J]. INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S159 - S159
[10] Retrospective study of type 2 diabetes mellitus (T2DM) patients not optimally controlled by metformin monotherapy
He, J.
Neslusan, C.
[J]. VALUE IN HEALTH, 2008, 11 (03) : A18 - A18

← 1 2 3 4 5 →